000 02770cam a2200361Ia 4500
001 96326
003 ES-MaUEC
005 20230102112749.0
006 m o d
007 cr |n|||||||||
008 170712s2017 sz o 000 0 eng d
020 _a3319522221
_q(electronic bk.)
020 _a9783319522227
_q(electronic bk.)
020 _z3319522213
020 _z9783319522210
040 _aYDX
_cYDX
_dN$T
_dGW5XE
_dN$T
_dEBLCP
_dOCLCF
_dKOS
_dOCLCO
_dYDX
_dOCLCO
_dUAB
_dOCLCO
_dESU
_dAZU
_dUPM
_dIOG
_dCOO
_dOCLCQ
_dMERER
_dOCLCQ
_dOCLCO
_dOCLCA
_dES-MaUEC
_bspa
050 4 _aRC927.5.P6
_b2017 EB
245 0 0 _aPolymyalgia rheumatica and giant cell arteritis
_cJozef Rovenský, Burkhard Leeb, Viera Štvrtinová, Richard Imrich, editors.
250 _a3rd ed.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
505 0 _aPolymyalgia Rheumatica and Giant Cell Arteritis -- an overview with a focus on important factors contributing to the severity of the disease -- Diagnostic criteria for PMR and GCA -- Polymyalgia Rheumatica, Temporal Arteritis and Occurrence of Malignant Tumors -- sine syndromes in PMR and GCA -- GCA and Takayasu's disease -- Vascular complications of PMR and GCA -- Coronary involvement and atherosclerosis in Giant Cell Arteritis -- T cells and their role in Polymyalgia Rheumatica -- Cytokines in Polymyalgia Rheumatica and Giant Cell Arteritis -- Genetic factors in Giant Cell Arteritis and Polymyalgia Rheumatica -- Chronobiology of Polymyalgia Rheumatica and Giant Cell Arteritis -- Endocrinologic changes in PMR and GCA -- Imaging techniques, e.g. Ultrasonography, PET/18FDG in PMR and GCA -- Histopathology of Giant Cell (temporal) Arteritis -- changes in aorta -- Management of PMR and GCA -- Biologicals in the treatment of Polymyalgia Rheumatica and Giant Cell Arteritis -- Therapy of resistant forms of PMR and GCA -- Monitoring tools for PMR and GCA.
520 3 _aThis monograph offers current insights into polymalgia rheumatica and giant cell arthritis. It covers the pathophysiology of these diseases plus their genetic, immunologic and endocrinologic mechanisms. It also addresses the latest in diagnosis and treatment.
650 7 _aReumatismo
_2embne
_0(OCoLC)fst00942464
_0
_9138755
700 1 _aRovenský, Jozef.
_997177
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-52222-7
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c96326
_d96326
_x1